Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/11151
Title: Sleep Quality Affects Humoral Response in Recipients of Two-Dose Sinovac Vaccines
Authors: Hananta, Linawati
Larasati, Victoria Surilena
Keywords: Antibody,
SARSCoV-2,
Sleep Quality,
COVID-19 Vaccine
Issue Date: Apr-2023
Publisher: Jurusan Kesehatan Masyarakat Fakultas Ilmu Keolahragaan (UNNES)
Abstract: Abstract To curb the COVID-19 pandemic, the government distributed Sinovac vaccines. Sleep mediates immune function, including post-vaccination antibody response. This study aimed to analyze whether there was a difference in post-vaccination antibody levels in Sinovac vaccine recipients with poor and good sleep quality. This study used analytical observations of recipients of the two-dose Sinovac vaccine in 2021. Primary data included age, sex, the Pittsburgh Sleep Quality Index (PSQI) questionnaire, and post-vaccination IgG-SARS-CoV-2 antibody levels. The PSQI and IgG SARS-CoV-2 antibody levels were measured a month after the second vaccination. Participants with non-reactive antibody levels before the first vaccination were included, and participants with incomplete data were excluded. The Mann-Whitney test was used to find associations between sleep quality and post-vaccination IgG SARS-CoV-2 levels. The univariate analysis showed that of 54 participants, 37 (68.5%) were male, and 28 (51.9%) had poor sleep quality. 15 participants (27.78%) were in the 36-45 age group, and median antibody levels in participants who received the second Sinovac Vaccine was 223.5 (199.01) units/mL. Postvaccination IgG SARS-CoV-2 antibody levels were significantly associated with sleep quality (p=0.036).
URI: http://localhost:8080/xmlui/handle/123456789/11151
ISSN: 2355-3596
Appears in Collections:VOL 18 NO 4 2023

Files in This Item:
File Description SizeFormat 
6. 41950-117793-2-PB.pdf225.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.